S
BSX icon

SignatureFD’s Boston Scientific BSX Stock Holding History

SignatureFD’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
32,736
+1,307
+4% +$105K 0.03% 224
2025
Q4 		$3M Buy
31,429
+156
+0.5% +$15.3K 0.05% 158
2025
Q3 		$3.05M Sell
31,273
-804
-3% -$83.3K 0.05% 156
2025
Q2 		$3.45M Sell
32,077
-344
-1% -$34.8K 0.06% 126
2025
Q1 		$3.27M Buy
32,421
+3,184
+11% +$321K 0.06% 122
2024
Q4 		$2.61M Buy
29,237
+1,368
+5% +$120K 0.05% 139
2024
Q3 		$2.34M Sell
27,869
-77
-0.3% -$6.07K 0.04% 149
2024
Q2 		$2.15M Buy
27,946
+1,339
+5% +$98K 0.04% 153
2024
Q1 		$1.82M Buy
26,607
+1,317
+5% +$84.7K 0.04% 180
2023
Q4 		$1.46M Buy
25,290
+259
+1% +$13.8K 0.03% 210
2023
Q3 		$1.32M Buy
25,031
+2,317
+10% +$122K 0.03% 206
2023
Q2 		$1.23M Buy
22,714
+1,069
+5% +$55.8K 0.03% 213
2023
Q1 		$1.08M Buy
21,645
+922
+4% +$43.5K 0.03% 224
2022
Q4 		$959K Buy
20,723
+3,235
+18% +$140K 0.03% 238
2022
Q3 		$677K Buy
17,488
+4,437
+34% +$178K 0.02% 286
2022
Q2 		$486K Sell
13,051
-820
-6% -$33.4K 0.02% 377
2022
Q1 		$614K Buy
13,871
+1,453
+12% +$63K 0.02% 340
2021
Q4 		$528K Buy
12,418
+2,360
+23% +$99.2K 0.02% 375
2021
Q3 		$436K Buy
10,058
+1,056
+12% +$46.7K 0.02% 416
2021
Q2 		$385K Buy
9,002
+1,528
+20% +$64.3K 0.02% 443
2021
Q1 		$289K Buy
7,474
+827
+12% +$31.3K 0.01% 459
2020
Q4 		$239K Sell
6,647
-1,403
-17% -$50.6K 0.01% 479
2020
Q3 		$308K Sell
8,050
-693
-8% -$26.7K 0.02% 351
2020
Q2 		$307K Sell
8,743
-469
-5% -$16.9K 0.02% 327
2020
Q1 		$301K Buy
9,212
+68
+0.7% +$2.66K 0.03% 298
2019
Q4 		$413K Buy
9,144
+1,311
+17% +$54.9K 0.03% 277
2019
Q3 		$319K Buy
7,833
+495
+7% +$21K 0.03% 288
2019
Q2 		$315K Buy
7,338
+575
+9% +$22.1K 0.03% 273
2019
Q1 		$260K Buy
6,763
+2,040
+43% +$77.9K 0.02% 313
2018
Q4 		$167K Sell
4,723
-9,489
-67% -$344K 0.02% 420
2018
Q3 		$547K Buy
14,212
+361
+3% +$12.6K 0.06% 177
2018
Q2 		$453K Sell
13,851
-991
-7% -$29.9K 0.05% 195
2018
Q1 		$405K Buy
+14,842
New +$403K 0.05% 181
2016
Q4 		– Sell
-1,285
Closed -$31K – 375
2016
Q3 		$31K Buy
1,285
+478
+59% +$11.4K ﹤0.01% 664
2016
Q2 		$19K Buy
807
+33
+4% +$714 ﹤0.01% 732
2016
Q1 		$15K Buy
774
+315
+69% +$5.53K ﹤0.01% 739
2015
Q4 		$8K Sell
459
-291
-39% -$5.21K ﹤0.01% 767
2015
Q3 		$12K Buy
750
+595
+384% +$10.2K ﹤0.01% 636
2015
Q2 		$3K Buy
+155
New +$2.77K ﹤0.01% 821
2014
Q3 		– Sell
-506
Closed -$6K – 727
2014
Q2 		$6K Buy
+506
New +$6.58K ﹤0.01% 547

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SignatureFD's BSX Position: Q1 2026 in Review

SignatureFD increased its Boston Scientific (BSX) stake by 4.2% in Q1 2026, buying an estimated $105K and bringing the position to 32,736 shares worth $2.05M. The position accounts for 0.03% of the portfolio, ranked #224.

SignatureFD first reported a position in BSX in Q2 2014 and has held it in 40 quarters since. The position peaked at $3.45M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SignatureFD held 32,736 shares of Boston Scientific worth $2.05M as of Q1 2026.
  • SignatureFD bought 1,307 Boston Scientific shares in Q1 2026, an estimated $105K.
  • Boston Scientific made up 0.03% of SignatureFD's portfolio in Q1 2026, its #224 holding.
  • SignatureFD first reported a position in Boston Scientific in Q2 2014 and has held it in 40 quarters since.
  • SignatureFD's Boston Scientific position peaked at $3.45M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.